Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Emilie Saussereau"'
Autor:
Marine Henry, Louis-Marie Bobay, Anne Chevallereau, Emilie Saussereau, Pieter-Jan Ceyssens, Laurent Debarbieux
Publikováno v:
PLoS ONE, Vol 10, Iss 1, p e0117163 (2015)
In a previous study, six virulent bacteriophages PAK_P1, PAK_P2, PAK_P3, PAK_P4, PAK_P5 and CHA_P1 were evaluated for their in vivo efficacy in treating Pseudomonas aeruginosa infections using a mouse model of lung infection. Here, we show that their
Externí odkaz:
https://doaj.org/article/2bf09a0e63f6445facecdc6666738aae
Autor:
Eric Morello, Emilie Saussereau, Damien Maura, Michel Huerre, Lhousseine Touqui, Laurent Debarbieux
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e16963 (2011)
Multidrug-resistant bacteria are the cause of an increasing number of deadly pulmonary infections. Because there is currently a paucity of novel antibiotics, phage therapy--the use of specific viruses that infect bacteria--is now more frequently bein
Externí odkaz:
https://doaj.org/article/10f4a585e0cd4548afdb7f397a3caa7c
Autor:
Raphaël Chiron, Laurent Debarbieux, Frédérique Carrié, Nicolas Molinari, Isabelle Sermet, Isabelle Vachier, Jean-Paul Pirnay, Emilie Saussereau, Nicolas Dufour, Benoit Godbert, Daniel De Vos
Publikováno v:
Clinical Microbiology and Infection
Clinical Microbiology and Infection, 2014, 20 (12), pp.O983-90. ⟨10.1111/1469-0691.12712⟩
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2014, 20 (12), pp.O983-90. ⟨10.1111/1469-0691.12712⟩
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2014, 20 (12), pp.O983-90. 〈10.1111/1469-0691.12712〉
Clinical Microbiology and Infection, 2014, 20 (12), pp.O983-90. ⟨10.1111/1469-0691.12712⟩
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2014, 20 (12), pp.O983-90. ⟨10.1111/1469-0691.12712⟩
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2014, 20 (12), pp.O983-90. 〈10.1111/1469-0691.12712〉
International audience; Bacteriophages have been shown to be effective for treating acute infections of the respiratory tract caused by antibiotic-resistant bacteria in animal models, but no evidence has yet been presented of their activity against p
Publikováno v:
Biologie Aujourd'hui
Biologie Aujourd'hui, 2013, 207 (3), pp.181-190. ⟨10.1051/jbio/2013017⟩
Biologie Aujourd'hui, EDP sciences, 2013, 207 (3), pp.181-190. ⟨10.1051/jbio/2013017⟩
Biologie Aujourd'hui, 2013, 207 (3), pp.181-190. ⟨10.1051/jbio/2013017⟩
Biologie Aujourd'hui, EDP sciences, 2013, 207 (3), pp.181-190. ⟨10.1051/jbio/2013017⟩
International audience; Bacteriophages were discovered in the early 20th century and rapidly used to treat bacterial infections in humans. As the first specific antibacterial agents, they were used worldwide until antibiotics ramped up. Thereafter, r
Autor:
Emilie Saussereau, Aleksander Edelman
Publikováno v:
Archives de Pédiatrie. 19:S13-S16
Mutations in cystic fibrosis transmembrane conductance regulator gene, CFTR, are responsible for cystic fibrosis, CF, a channelopathie. CFTR protein is a multifunctional protein with a main function of Cl(-) channel. CFTR is expressed in epithelia (u
Autor:
Aleksander Edelman, Wael M. Rabeh, Emilie Saussereau, Harald Herrmann, Franck Brouillard, Sara Bitam, Julien Colas, Noélie Davezac, Stéphanie Trudel, Isabelle Sermet-Gaudelus, Grazyna Faure, Mario Ollero, Janine Fritsch, Gergely L. Lukacs, Ida Chiara Guerrera
Publikováno v:
Human Molecular Genetics. 21:623-634
We have previously reported an increased expression of cytokeratins 8/18 (K8/K18) in cells expressing the F508del mutation of cystic fibrosis transmembrane conductance regulator (CFTR). This is associated with increased colocalization of CFTR and K18
Autor:
Louis-Marie Bobay, Pieter-Jan Ceyssens, Laurent Debarbieux, Anne Chevallereau, Marine Henry, Emilie Saussereau
Publikováno v:
PLoS ONE, Vol 10, Iss 1, p e0117163 (2015)
PLoS ONE
PLoS ONE, Public Library of Science, 2015, 10 (1), pp.e0117163. ⟨10.1371/journal.pone.0117163⟩
PLoS ONE, 2015, 10 (1), pp.e0117163. ⟨10.1371/journal.pone.0117163⟩
PLoS ONE
PLoS ONE, Public Library of Science, 2015, 10 (1), pp.e0117163. ⟨10.1371/journal.pone.0117163⟩
PLoS ONE, 2015, 10 (1), pp.e0117163. ⟨10.1371/journal.pone.0117163⟩
International audience; In a previous study, six virulent bacteriophages PAK_P1, PAK_P2, PAK_P3, PAK_P4, PAK_P5 and CHA_P1 were evaluated for their in vivo efficacy in treating Pseudomonas aeruginosa infections using a mouse model of lung infection.
Autor:
Siradiou Diallo, Delphine Roussel, Isabelle Sermet-Gaudelus, Emilie Saussereau, Laurent Debarbieux, Aleksander Edelman
Publikováno v:
PLoS ONE
PLoS ONE, 2013, 8 (3), pp.e57317. ⟨10.1371/journal.pone.0057317⟩
PLoS ONE, Vol 8, Iss 3, p e57317 (2013)
PLoS ONE, Public Library of Science, 2013, 8 (3), pp.e57317. ⟨10.1371/journal.pone.0057317⟩
PLoS ONE, Public Library of Science, 2013, 8 (3), pp.e57317. 〈10.1371/journal.pone.0057317〉
PLoS ONE, 2013, 8 (3), pp.e57317. ⟨10.1371/journal.pone.0057317⟩
PLoS ONE, Vol 8, Iss 3, p e57317 (2013)
PLoS ONE, Public Library of Science, 2013, 8 (3), pp.e57317. ⟨10.1371/journal.pone.0057317⟩
PLoS ONE, Public Library of Science, 2013, 8 (3), pp.e57317. 〈10.1371/journal.pone.0057317〉
BACKGROUND:Treatments designed to correct cystic fibrosis transmembrane conductance regulator (CFTR) defects must first be evaluated in preclinical experiments in the mouse model of cystic fibrosis (CF). Mice nasal mucosa mimics the bioelectric defec
Autor:
Emilie Saussereau, Delphine Roussel, Marc Paulais, Pierre Boulanger, Jean-Michel Sallenave, Laurette Malleret, Loïc Guillot, Saw-See Hong, Manon Ruffin, Michel Huerre, Azzaq Belaaouaj, Delphyne Descamps, Aleksander Edelman, Michel Chignard, Mathieu Le Gars, Olivier Tabary
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
American Journal of Respiratory and Critical Care Medicine, 2013, 187 (2), pp.170-179. ⟨10.1164/rccm.201205-0875OC⟩
American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2013, 187 (2), pp.170-179. ⟨10.1164/rccm.201205-0875OC⟩
American Journal of Respiratory and Critical Care Medicine, 2013, 187 (2), pp.170-179. ⟨10.1164/rccm.201205-0875OC⟩
American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2013, 187 (2), pp.170-179. ⟨10.1164/rccm.201205-0875OC⟩
Comment in :The yin and yang of cystic fibrosis transmembrane conductance regulator function: implications for chronic lung disease. [Am J Respir Crit Care Med. 2013]; International audience; RATIONALE:Cystic fibrosis transmembrane conductance regula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d585eceac22851da0d815c97a7fbefd1
https://www.hal.inserm.fr/inserm-02448131
https://www.hal.inserm.fr/inserm-02448131
Publikováno v:
Biologie Aujourd'hui
Biologie Aujourd'hui, EDP sciences, 2013, 207 (3), pp.181-190. ⟨10.1051/jbio/2013017⟩
Biologie Aujourd'hui, EDP sciences, 2013, 207 (3), pp.181-190. ⟨10.1051/jbio/2013017⟩
International audience; Bacteriophages were discovered in the early 20th century and rapidly used to treat bacterial infections in humans. As the first specific antibacterial agents, they were used worldwide until antibiotics ramped up. Thereafter, r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3f0607d6f6418f9bcbda451a24a50ccb
https://hal-pasteur.archives-ouvertes.fr/pasteur-03164767
https://hal-pasteur.archives-ouvertes.fr/pasteur-03164767